인쇄하기
취소

Yuhan Corp. receives IR52 Chang Young Sil award

Published: 2006-07-25 06:57:00
Updated: 2006-07-25 06:57:00
The development of a branded product Voglicose (voglibose) for the treatment of diabetes using a platform technology that shows far more economical and simpler than the existing patented methods has Yuhan Corporation the domestically prestigious IR52 Chang Young Sil Award, the Korea Industrial Technology Association (KITA) said.

The KITA said the production process of voglibose proves to be ...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.